Fas ligand expression in BRCA1-associated hereditary breast carcinoma clearly differs from that in sporadic breast carcinoma

Author： Ito Y.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.66, Iss.2, 2001-03, pp. : 95-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loss of BRCA1 expression in sporadic male breast carcinoma

By Sun X.   Gong Y.   Rao M.S.   Badve S.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 1, 2002-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer

By Jin Wei   Chen Li   Chen Ying   Xu Si-guang   Di Gen-hong   Yin Wen-jin   Wu Jiong   Shao Zhi-ming  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 359-373

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles

By Matros Evan  

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 179-186

Springer Publishing Company

Access to resources Recommend Favorite

Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer

By          

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1807-1813

Spandidos Publications

Access to resources Recommend Favorite

BRCA1 promoter hypermethylation in sporadic epithelial ovarian carcinoma: Association with low expression of BRCA1, improved survival and coexpression of DNA methyltransferases

By                              

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1088-1096

Spandidos Publications

Access to resources Recommend Favorite